Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Viatocinon CMI 07 Dec 2021
Tarka CMI 07 Dec 2021
Fenofibrate Viatris CMI 07 Dec 2021
Adenuric tablets PI 07 Dec 2021
Vaxigrip Tetra PI 06 Dec 2021

New products

Product name Type Date released
Comirnaty [Tris/Sucrose Presentation] CMI 07 Dec 2021
Comirnaty [Tris/Sucrose Presentation] PI 07 Dec 2021
Methylphenidate-Teva XR CMI 06 Dec 2021
Methylphenidate-Teva XR PI 06 Dec 2021
Empliciti PI 02 Dec 2021